Organovo Holdings, Inc. (ONVO) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Organovo Holdings, Inc. (ONVO) Bundle
Explore Organovo Holdings, Inc. (ONVO) financial future with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate the intrinsic value of Organovo Holdings, Inc. (ONVO) and refine your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.2 | .0 | 1.5 | .4 | .1 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | -100 | 0 | -75.33 | -70.54 | -61.47 | -61.47 | -61.47 | -61.47 | -61.47 |
EBITDA | -20.3 | -16.8 | -11.3 | -17.4 | -14.8 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | -925.91 | 100 | -755.8 | -4712.97 | -13583.49 | -60 | -60 | -60 | -60 | -60 |
Depreciation | 1.1 | .0 | .1 | .3 | .3 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 52 | 100 | 9.47 | 79.19 | 256.88 | 68.13 | 68.13 | 68.13 | 68.13 | 68.13 |
EBIT | -21.5 | -16.8 | -11.5 | -17.7 | -15.1 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | -977.91 | 100 | -765.27 | -4792.16 | -13840.37 | -60 | -60 | -60 | -60 | -60 |
Total Cash | 27.4 | 37.4 | 28.7 | 16.0 | 2.9 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | .0 | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 5.05 | 100 | 0 | 41.08 | 30.28 | 35.28 | 35.28 | 35.28 | 35.28 | 35.28 |
Inventories | .0 | .0 | .0 | .0 | .3 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 0.000045537341 | 100 | 0 | 0.00027027027 | 272.48 | 40 | 40 | 40 | 40 | 40 |
Accounts Payable | .7 | .3 | .4 | .3 | .6 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 32.79 | 100 | 27.67 | 89.46 | 575.23 | 69.98 | 69.98 | 69.98 | 69.98 | 69.98 |
Capital Expenditure | .0 | -.4 | -.4 | -.4 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 0 | 100 | -27.27 | -107.03 | -38.53 | -33.16 | -33.16 | -33.16 | -33.16 | -33.16 |
Tax Rate, % | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 | -0.01363419 |
EBITAT | -21.5 | -16.8 | -11.5 | -17.7 | -15.1 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -19.7 | -17.5 | -11.6 | -18.1 | -14.7 | -.3 | .0 | .0 | .0 | .0 |
WACC, % | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 |
PV UFCF | ||||||||||
SUM PV UFCF | -.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 0 | |||||||||
Net Debt | -2 | |||||||||
Equity Value | 1 | |||||||||
Diluted Shares Outstanding, MM | 9 | |||||||||
Equity Value Per Share | 0.13 |
What You Will Get
- Pre-Filled Financial Model: Utilize Organovo’s actual data for accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, profit margins, WACC, and other critical parameters.
- Instant Calculations: Real-time updates provide immediate feedback as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, allowing for repeated application in comprehensive forecasts.
Key Features
- 🔍 Real-Life ONVO Financials: Pre-filled historical and projected data for Organovo Holdings, Inc. (ONVO).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Organovo's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Organovo's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Organovo Holdings, Inc. (ONVO).
- Step 2: Review Organovo's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the results for investment strategies.
Why Choose This Calculator for Organovo Holdings, Inc. (ONVO)?
- Designed for Experts: A specialized tool utilized by researchers, investment analysts, and healthcare consultants.
- Accurate Data: Organovo’s historical and projected financials are preloaded to ensure precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance makes the process straightforward.
Who Should Use This Product?
- Investors: Accurately estimate Organovo Holdings, Inc.'s (ONVO) fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Organovo Holdings, Inc. (ONVO).
- Consultants: Quickly adapt the template for valuation reports tailored to Organovo Holdings, Inc. (ONVO) clients.
- Entrepreneurs: Gain insights into financial modeling strategies employed by leading biotech firms like Organovo Holdings, Inc. (ONVO).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Organovo Holdings, Inc. (ONVO).
What the Template Contains
- Preloaded ONVO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.